A double-blind, placebo-controlled, randomized study evaluating the effect of paliperidone extended-release tablets on sleep architecture in patients with schizophrenia-Reference-Cited by-同舟云学术

A double-blind, placebo-controlled, randomized study evaluating the effect of paliperidone extended-release tablets on sleep architecture in patients with schizophrenia

Published:2007-09 Issue:5 Volume:22 Page:299-308
ISSN:0268-1315
Container-title:International Clinical Psychopharmacology
language:en
Short-container-title:International Clinical Psychopharmacology

Author:

Luthringer Remy,Staner Luc,Noel Nadine,Muzet Muriel,Gassmann-Mayer Cristiana,Talluri Krishna,Cleton Adriaan,Eerdekens Marielle,Battisti Wendy P.,Palumbo Joseph M.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Psychiatry and Mental health

Reference36 articles.

1. A Rating Scale for Drug-Induced Akathisia

2. Insomnia as a predictor for symptom worsening following antipsychotic withdrawal in schizophrenia

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adverse effects of antipsychotics on sleep in patients with schizophrenia. Systematic review and meta-analysis;Frontiers in Psychiatry;2023-06-27

2. Analysis of the effect of brexpiprazole on sleep architecture in patients with schizophrenia: A preliminary study;Neuropsychopharmacology Reports;2023-01-06

3. Drug-Induced Insomnia and Excessive Sleepiness;Sleep Medicine Clinics;2022-09

4. Sleep in Patients with Schizophrenia or Unipolar or Bipolar Disorder: The Effect of Second-Generation Antipsychotic Drugs;Sleep and Neuropsychiatric Disorders;2022

5. Benefits and harms of Risperidone and Paliperidone for treatment of patients with schizophrenia or bipolar disorder: a meta-analysis involving individual participant data and clinical study reports;BMC Medicine;2021-08-25